Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Antimicrobial Agents and Chemotherapy
|
October 19, 2000
PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages
M Martin, N Serradji, N Dereuddre-Bosquet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes
X Wang, F Rondu, A Lamouri, et al.
Journal of Medicinal Chemistry
|
June 8, 2000
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication
N Serradji, O Bensaid, M Martin, et al.
British Journal of Pharmacology
|
October 2, 1998
Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM
A Pelé-Tounian, X Wang, F Rondu, et al.
Journal of Medicinal Chemistry
|
November 26, 1997
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines
F Rondu, G Le Bihan, X Wang, et al.
Journal of Medicinal Chemistry
|
May 7, 1999
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline
G Le Bihan, F Rondu, A Pelé-Tounian, et al.
European Journal of Pharmacology
|
August 17, 1999
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats
A Pelé-Tounian, S L Chan, F Rondu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Antimicrobial Agents and Chemotherapy
|
October 19, 2000
PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages
M Martin, N Serradji, N Dereuddre-Bosquet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes
X Wang, F Rondu, A Lamouri, et al.
Journal of Medicinal Chemistry
|
June 8, 2000
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication
N Serradji, O Bensaid, M Martin, et al.
British Journal of Pharmacology
|
October 2, 1998
Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM
A Pelé-Tounian, X Wang, F Rondu, et al.
Journal of Medicinal Chemistry
|
November 26, 1997
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines
F Rondu, G Le Bihan, X Wang, et al.
Journal of Medicinal Chemistry
|
May 7, 1999
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline
G Le Bihan, F Rondu, A Pelé-Tounian, et al.
European Journal of Pharmacology
|
August 17, 1999
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats
A Pelé-Tounian, S L Chan, F Rondu, et al.
Page
of 5